International Clinical Trial: A single-dose, randomized, open-label, two-period, two-sequence, two-way crossover bioequivalence pilot study of vericiguat tablets in healthy study participants under fed conditions

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132689) titled 'A single-dose, randomized, open-label, two-period, two-sequence, two-way crossover bioequivalence pilot study of vericiguat tablets in healthy study participants under fed conditions' on Sept. 17.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: Deyang People's Hospital

Condition: Chronic systolic (congestive) heart failure/heart failure with reduced ejection fraction

Intervention: T-R Group:Cycle 1: Take Test Preparation T (1 tablet), Cycle 2: Take Reference Preparation R (1 tablet)

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-09-21

Target Sa...